Lilly buys inflammation biotech Ventyx for $1.2B in wake of Parkinson's, CV readouts
Fuente:
FierceBiotech
Ventyx has achieved its goal of securing Big Pharma commitment to its pipeline, with Eli Lilly swooping in to buy the inflammation biotech outright for $1.2 billion.